Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

Summary

This reports provides a data-driven overview of the current and future competitive landscape in Dravet Syndrome therapeutics.

Synopsis

  • In 2022, there will be more than 123,000 diagnosed prevalent cases of Dravet syndrome across 16 pharmaceutical markets.
  • Two FDA-approved branded marketed drugs are available for the treatment of Dravet syndrome.
  • The Dravet syndrome pipeline consists of 38 pharmaceuticals spanning all stages of development, with more than 90% of drugs in early-stage development.
  • Commercial sponsors dominate clinical trial development in Dravet syndrome, with the US emerging as the key country for conducting trials in Dravet syndrome.
  • Deals involving licensing and partnership for Dravet syndrome assets are the most common types of deals globally.
  • Companies are increasingly focusing on R&D activities to develop anti-epileptic drugs (AEDs) with novel mechanisms of action.
  • Scope

    GlobalData’s Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

    Components of the report include -
  • Disease Landscape
  • Disease Overview
  • Epidemiology Overview
  • Treatment Overview
  • Marketed Products Assessment
  • Breakdown by Mechanism of Action and Route of Administration
  • Product Profiles with Sales Forecast
  • Pipeline Assessment
  • Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
  • Late-to-mid-stage Pipeline Drugs
  • Clinical Trials Assessment
  • Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
  • Enrolment Analytics, Site Analytics, Feasibility Analysis
  • Deals Landscape
  • Mergers, Acquisitions, and Strategic Alliances by Region
  • Overview of Recent Deals
  • Future Market Catalysts
  • Reasons to Buy
    • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
    • Develop business strategies by understanding the trends shaping and driving the Dravet Syndrome market.
    • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Dravet Syndrome market in the future.
    • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
    • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
    • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.


    • Report Scope
    • Key Findings
    • Disease Overview
    • Epidemiology Overview
      • Epidemiology Overview: Total Prevalent Cases of Dravet Syndrome in 2022 and 2027
    • Treatment Overview
      • Treatment Guidelines
    • Marketed Drugs Assessment
      • Marketed Drugs Overview
      • Marketed Drugs – Overview by Mechanism of Action
      • Marketed Drugs – Overview by Route of Administration
      • Marketed Drug Profile: GW Pharmaceuticals/Neo Pharm’s Epidiolex/Epidyolex
      • Marketed Drug Profile: Zogenix’s Fintepla
    • Pipeline Drugs Assessment
      • Pipeline Drugs Overview – Phase III and Phase II Pipeline Drugs in Dravet Syndrome
      • Pipeline Drugs – Overview by Development Stage
      • Pipeline Drugs – Overview by Molecule Type
      • Pipeline Drugs – Overview by Mechanism of Action
      • Pipeline Drugs – Overview by Route of Administration
      • Pipeline Drugs – Phase Transition Success Rates and Likelihood of Approval in Central Nervous System and Dravet Syndrome
      • Pipeline Drugs – Drug-Specific Phase Transition Success Rates and Likelihood of Approval in Dravet Syndrome
    • Clinical Trials Assessment
      • Clinical Trials in Dravet Syndrome – Historical Overview
      • Clinical Trials in Dravet Syndrome – Overview by Phase
      • Clinical Trials in Dravet Syndrome – Overview by Status
      • Clinical Trials in Dravet Syndrome – Overview by Phase for Ongoing and Planned Trials
      • Clinical Trials in Dravet Syndrome – Trials with a Virtual Component
      • Clinical Trials in Dravet Syndrome – Geographic Overview
      • Clinical Trials in Dravet Syndrome – Single-Country and Multinational Trials by Region
      • Clinical Trials in Dravet Syndrome – Top 20 Sponsors with Breakdown by Phase
      • Clinical Trials in Dravet Syndrome – Top 20 Sponsors with Breakdown by Status
      • Clinical Trials in Dravet Syndrome – Overview by Endpoint Status
      • Clinical Trials in Dravet Syndrome – Overview by Race and Ethnicity
      • Clinical Trials in Dravet Syndrome – Enrollment Data
      • Clinical Trials in Dravet Syndrome – Overview of Sites by Geography
      • Clinical Trials in Dravet Syndrome – Top 20 Countries for Trial Sites
      • Clinical Trials in Dravet Syndrome – Top 20 Sites Globally
      • Clinical Trials – Feasibility Analysis: Geography Overview
      • Clinical Trials – Feasibility Analysis: Benchmark Models for Dravet Syndrome
    • Deals Landscape
      • Deals Landscape – Mergers, Acquisitions, and Strategic Alliances in Dravet Syndrome by Region
      • Deals Landscape – Recent Mergers, Acquisitions, and Strategic Alliances in Dravet Syndrome
    • Commercial Assessment
      • Commercial Assessment – Key Market Players in Dravet Syndrome
    • Future Market Catalysts
      • Future Market Catalysts – Upcoming Market Catalysts in Dravet Syndrome
    • Appendix
      • Methodology
      • Methodology – Sales Forecasts
      • Methodology – PTSR and LoA Analysis
      • About the Authors
    • Contact Us
      • Contact Us – A Global Network of Offices

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings